Background and Objectives: The aim of our single-center cohort study was the determination of the influence of the intrauterine lavage of granulocyte colony-stimulating growth factor (G-CSF) on clinical pregnancy rate in patients with a history of implantation failure older than 40 years. Materials and Methods: The study was conducted in Ferticare Prague SE between May 2018 and June 2020. Overall, 115 patients were distributed into two arms, with 48 subjects in the experimental and 67 in the control arm. All women have had a previous history of unsuccessful history of infertility treatment with their own genetic material and at least one ineffective cycle with the donated oocytes. The experimental arm underwent the intrauterine lavage of 0.5 mL of pure G-CSF from 120 to 48 h prior to embryo transfer. Results: The clinical pregnancy rate was 63.3% in the experimental arm and 47.8% in the control arm (p = 0.097 for Pearsonߣs χ2, and p = 0.133 for Fisher's exact test). However, the mean endometrial thickness on the day of embryo transfer did not appear to be statistically different (p = 0.139). Only the difference in endometrium thickness growth was statistically significant (p = 0.023). The increase in pregnancy rate is still encouraging for the future, even if it is not significant. Conclusion: Our study suggests the trend of increased pregnancy rate after the intrauterine G-CSF lavage in the interval of 120-48 h prior to embryo transfer.

1st Faculty of Medicine Charles University Prague 120 00 Prague Czech Republic

Department of Demography and Geodemography Faculty of Science Charles University Prague 120 00 Prague Czech Republic

Department of Health Studies Polytechnic College Jihlava 586 01 Jihlava Czech Republic

Department of Obstetrics and Gynecology 2nd Faculty of Medicine Charles University Prague 150 00 Prague Czech Republic

FertiCarePrague SE 150 00 Prague Czech Republic

Zobrazit více v PubMed

Stastna A., Sidlo L., Kocourkova J., Fait T. Does advanced maternal age explain the longer hospitalisation of mothers after childbirth? PLoS ONE. 2023;18:e0284159. doi: 10.1371/journal.pone.0284159. PubMed DOI PMC

Won J., Lee D., Lee Y., Hong S., Kim J.H., Kang Y. The therapeutic effects optimal timing of G-CSF intrauterine administration during IVF-ET. Life Sci. 2023;317:121444. doi: 10.1016/j.lfs.2023.121444. PubMed DOI

Simon C., Martin J.C., Meseguer M., Caballero-Campo P., Valbuena D., Pellicer A. Embryonic regulation of endometrial molecules in human implantation. J. Reprod. Fertil. Suppl. 2000;C55:43–53. PubMed

Garcia J.E., Rosenwaks Z. Development of in vitro fertilization in the United States: A conversation between. Fertil. Steril. 2018;110:14–18. doi: 10.1016/j.fertnstert.2018.04.011. PubMed DOI

Dieamant F., Vagnini L.D., Peterson C.G., Mauri A.L., Renzi A. New therapeutic protocol for improvement of endometrial receptivity (PRIMER) for patients with recurrent implantation failure (RIF)—A pilot study. JBRA Assist. Reprod. 2019;23:250–254. doi: 10.5935/1518-0557.20190035. PubMed DOI PMC

Bashiri A., Halper K.I., Orvieto R. Recurrent Implantation Failure-update overview on etiology, diagnosis, treatment and future directions. Reprod. Biol. Endocrinol. 2018;16:121. doi: 10.1186/s12958-018-0414-2. PubMed DOI PMC

Comins-Boo A., Garcia-Segovia A., Nunez P. Evidence-based Update: Immunological Evaluation of Recurrent Implantation Failure. Reprod. Immunol. Open Access. 2016;1:1–8. doi: 10.21767/2476-1974.100024. DOI

Kolibianakis E.M., Venetis C.A. Recurrent Implantation Failure. CRC Press; Boca Raton, FL, USA: 2019. 176p

Pirtea P., De Zeigler D., Tao X., Sun L., Zhan Y., Azoubi J.M. Rate of recurrent implantation failure is low: Results of three successive frozen euploid single embryo transfers. Fertil. Steril. 2021;115:45–53. doi: 10.1016/j.fertnstert.2020.07.002. PubMed DOI

Ekanayake D.L., Malopolska M.M., Schwarz T., Tuz R., Bartlewski P.M. The roles and expression of HOXA/Hoxa10 gene: A prospective marker of mammalian female fertility? Reprod. Biol. 2022;22:100647. doi: 10.1016/j.repbio.2022.100647. PubMed DOI

Harper M.J. The implantation Window. Baillieres Clin. Obstet. Gynaecol. 1992;6:351–371. doi: 10.1016/S0950-3552(05)80092-6. PubMed DOI

Patrizio P., Shoham G., Shoham Z., Leong M., Barad D.H., Gleicher N. Worldwide live births following the transfer of chromosomally “abnormal” embryos after PGT/A: Results of a worldwide web-based survey. J. Assist. Reprod. Genet. 2019;36:1599–1607. doi: 10.1007/s10815-019-01510-0. PubMed DOI PMC

Ata B., Kaplan B., Danzer H., Glassner M., Opsahl M., Lin Tan S., Munne S. Array CGH analysis shown that aneuploidy is not related to the number of embryos generated. Reprod. Biomed. Online. 2012;24:14–20. doi: 10.1016/j.rbmo.2012.02.009. PubMed DOI

Treff N.R., Frantisiak J.M. Detection of segmental aneuploidy and mosaicism in the human preimplantation embryo: Technical considirations and limitations. Fertil. Steril. 2017;107:27–31. doi: 10.1016/j.fertnstert.2016.09.039. PubMed DOI

Kushniruk N., Fait T. The most valuable predictors of endometrial receptivity. Ces. Gynekol. 2014;79:269–275. PubMed

Horne A.W., Lalani E.N., Margara R.A., White J.O. The effects of sex steroid hormones and interleukin-1-beta on MUC1 expression in endometrial epithelial cell lines. Reproduction. 2006;131:733–742. doi: 10.1530/rep.1.00883. PubMed DOI

Minas V., Loutradis D., Makrigiannakis A. Factors controlling blastocyst implantation. Reprod. Bimed. Online. 2005;10:205–216. doi: 10.1016/S1472-6483(10)60942-X. PubMed DOI

Rosario G.X., Steward C.L. The multifaceted actions of leukemia inhibitory factor in mediating uterine receptivity and embryo implantation. Am. J. Reprod. Immunol. 2016;75:246–255. doi: 10.1111/aji.12474. PubMed DOI

Davari-Tahna F., Tehraninejad E.S., Ghazi M., Shahraki Z. The role of G-CSF in recurrent implantation failure: A randomized double blind placebo control trial. Int. J. Reprod. Bio. Med. 2016;14:737–742. PubMed PMC

Kalem Z., Kalem M.N., Bakirarar B., Kent E., Makrigiannakis A., Gurgan T. Intrauterine G-CSF Administration in Recurrent Implantation Failure (RIF): An Rct. Sci. Rep. 2020;10:5139. doi: 10.1038/s41598-020-61955-7. PubMed DOI PMC

Kamath M.S., Kirubakaran R., Sunkara S.K. Granulocyte-colony stimulating factor administration for subfertile women undergoing assisted reproduction. Cochrane Database. 2020;1:CD013226. doi: 10.1002/14651858.CD013226. PubMed DOI PMC

Kasvandik S., Saarma M., Kaart T., Rooda I., Velthut-Meikas A., Ehrenberg A. Uterine fluids proteins for minimally invasive assessment of endometrial receptivity. JCEM. 2020;105:219–230. doi: 10.1210/clinem/dgz019. PubMed DOI

Kunicki M., Łukaszuk K., Woclawek-Potocka I., Liss J., Kulwikowska P., Szczyptańska J. Evaluation of granulocyte colony-stimulating factor effects on treatment-resistant thin endometrium in women undergoing in vitro fertilization. Biomed. Res. Int. 2014;2014:913235. doi: 10.1155/2014/913235. PubMed DOI PMC

Dale D.C., Crawford J., Klippel Z., Reiner M., Osslund T., Fan E., Morrow K.P., Allcott K., Lyman G.H. A systematic literature review of the efficacy, affectiveness nad safety of filgrastim. Support. Care Cancer. 2018;26:7–20. doi: 10.1007/s00520-017-3854-x. PubMed DOI PMC

Armstrong S., MacKenzue J., Woodward B., Pacey A., Farquhar C. GM-CSF supplementation on culture media for women undergoing assisted reproduction. Cohrane Database Syst. Rev. 2020;7:CD013497. PubMed PMC

Xie Y., Zhang T., Tian Z., Zhang J., Wang W., Zhang H., Zeng Y., Ou J., Yang Y. Efficacy of intrauterine perfusion of G-CSF for infertile women with thin endometrium: A systematic review and meta-analysis. Am. J. Reprod. Immunol. 2017;2:78. doi: 10.1111/aji.12701. PubMed DOI

Hou Z., Jiang F., Yang J., Lui Y., Zha H., Yang X., Meng Y. What is the impact of granulocyte colony-stimulating factor (G-CSF) in subcutaneous injection or intrauterine infusion and during both the fresh and frozen embryo transfer cycles on recurrent implantation failure: A systemic review and meta-analysis? Reprod. Biol. Endocrinol. 2021;19:125. doi: 10.1186/s12958-021-00810-4. PubMed DOI PMC

Cimadomo D., de los Santos M.J., Griesinger G., Lainas G., Le Clef N., McLemon D.J., Montiean D., Toth B., Vermeulen N., Macklon N. ESHRE good practice recommendations on recurrent implantation failure. Hum. Reprod. Open. 2023;2023:hoad023. PubMed PMC

Paulson R.J. Preimplantation genetic screening: What is the clinical efficiency? Fertil. Steril. 2017;108:228–230. doi: 10.1016/j.fertnstert.2017.06.023. PubMed DOI

Hoozemans D.A., Schats R., Lambalk C.B., Hamburg R., Hompes P.G.A. Human embryo implantation: Current knowledge and clinical implications in assisted reproductive technology. Reprod. Biomed. Online. 2004;9:692–715. doi: 10.1016/S1472-6483(10)61781-6. PubMed DOI

Domínguez F., Pellicer A., Simon C. Embryonic regulation in the implantation processes. In: Gardner D.K., Weissman A., Howles C.M., editors. Textbook of Assisted Reproductive Techniques. 2nd ed. Tailor & Francis; London, UK: 2004. pp. 413–423.

Sehring J., Beltsos A., Jeelani R. Human implantation: The complex interplay between endometrial receptivity, inflammation, and the microbiome. Placenta. 2022;117:179–186. doi: 10.1016/j.placenta.2021.12.015. PubMed DOI

Yoo I., Chae S., Han J., Lee S., Kim H.J., Ka H. Leukemia inhibitory factor and its receptor: Expression and regulation in the porcine endometrium throughout the estrous cycle and pregnancy. Asian-Aust. J. Anim. Sci. 2019;32:192–200. doi: 10.5713/ajas.18.0429. PubMed DOI PMC

Enciso M., Aizpurua J., Rodriguez-Estrada B., Jurado I., Ferrandez-Rives M., Rodriguez E. The precise determination of the window of implantation significantly improves ART outcomes. Nature. 2021;11:13420. doi: 10.1038/s41598-021-92955-w. PubMed DOI PMC